Literature DB >> 24235906

Kleine-levin syndrome treated with clarithromycin.

Elham Rezvanian1, Nathaniel F Watson.   

Abstract

Kleine-Levin syndrome (KLS) is a rare sleep disorder characterized by periodic hypersomnia and various degrees of cognitive and behavioral disturbance, hyperphagia, and hypersexuality. Effective treatment is challenging. Stimulants marginally address sleepiness, but may increase irritability and do not improve cognitive and behavioral disturbances. Modafinil may shorten the symptomatic period but not the recurrence rate. Lithium and carbamazepine are beneficial in some cases, possibly related to similarities between KLS and affective disorders. Currently, no single medication is consistently successful in treating the syndrome. Here we report the short-term effect of clarithromycin in a patient with KLS.

Entities:  

Keywords:  Kleine-Levin; clarithromycin; hypersomnia

Mesh:

Substances:

Year:  2013        PMID: 24235906      PMCID: PMC3805810          DOI: 10.5664/jcsm.3176

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  7 in total

1.  A case of Kleine-Levin syndrome examined with SPECT and neuropsychological testing.

Authors:  A-M Landtblom; N Dige; K Schwerdt; P Säfström; G Granérus
Journal:  Acta Neurol Scand       Date:  2002-04       Impact factor: 3.209

Review 2.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

3.  Dynamic fMRI changes in Kleine-Levin Syndrome.

Authors:  Martha E Billings; Nathaniel F Watson; Bart P Keogh
Journal:  Sleep Med       Date:  2011-04-13       Impact factor: 3.492

4.  Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses.

Authors:  Y Dauvilliers; G Mayer; M Lecendreux; E Neidhart; R Peraita-Adrados; K Sonka; M Billiard; M Tafti
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

5.  Kleine-Levin syndrome: a systematic study of 108 patients.

Authors:  Isabelle Arnulf; Ling Lin; Nathan Gadoth; Jennifer File; Michel Lecendreux; Patricia Franco; Jamie Zeitzer; Betty Lo; Juliette H Faraco; Emmanuel Mignot
Journal:  Ann Neurol       Date:  2008-04       Impact factor: 10.422

6.  Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors.

Authors:  David B Rye; Donald L Bliwise; Kathy Parker; Lynn Marie Trotti; Prabhjyot Saini; Jacqueline Fairley; Amanda Freeman; Paul S Garcia; Michael J Owens; James C Ritchie; Andrew Jenkins
Journal:  Sci Transl Med       Date:  2012-11-21       Impact factor: 17.956

7.  Increased cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in Kleine-Levin syndrome.

Authors:  R K Koerber; R Torkelson; G Haven; J Donaldson; S M Cohen; M Case
Journal:  Neurology       Date:  1984-12       Impact factor: 9.910

  7 in total
  11 in total

Review 1.  Neuropsychiatric Effects of Antimicrobial Agents.

Authors:  Nicholas Zareifopoulos; George Panayiotakopoulos
Journal:  Clin Drug Investig       Date:  2017-05       Impact factor: 2.859

2.  Further experience using clarithromycin in patients with Kleine-Levin syndrome.

Authors:  Lynn Marie Trotti; Donald L Bliwise; David B Rye
Journal:  J Clin Sleep Med       Date:  2014-04-15       Impact factor: 4.062

3.  Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial.

Authors:  Lynn Marie Trotti; Prabhjyot Saini; Donald L Bliwise; Amanda A Freeman; Andrew Jenkins; David B Rye
Journal:  Ann Neurol       Date:  2015-06-30       Impact factor: 10.422

4.  General Anesthetic Management of a Patient With Kleine-Levin Syndrome.

Authors:  Masatoshi Fujita; Kentaro Mizuta
Journal:  Anesth Prog       Date:  2022-04-01

5.  Treatment of disorders of hypersomnolence.

Authors:  Olufemi Adenuga; Hrayr Attarian
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

6.  Cerebrospinal Fluid Orexin A Levels and Autonomic Function in Kleine-Levin Syndrome.

Authors:  Jing Yu Wang; Fang Han; Song X Dong; Jing Li; Pei An; Xiao Zhe Zhang; Yuan Chang; Long Zhao; Xue Li Zhang; Ya Nan Liu; Han Yan; Qing Hua Li; Yan Hu; Chang Jun Lv; Zhan Cheng Gao; Kingman P Strohl
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

Review 7.  Kleine-Levin Syndrome.

Authors:  Oliver Sum-Ping; Christian Guilleminault
Journal:  Curr Treat Options Neurol       Date:  2016-06       Impact factor: 3.598

Review 8.  Idiopathic Hypersomnia and Other Hypersomnia Syndromes.

Authors:  Lynn Marie Trotti; Isabelle Arnulf
Journal:  Neurotherapeutics       Date:  2021-01       Impact factor: 7.620

9.  The Kleine-Levin Syndrome: A Rare Disease with Often Delayed Diagnosis-A Report of Two Cases in the Department of Neurology of the University Hospital of Cocody (Côte d'Ivoire).

Authors:  Berthe Assi; Constance Yapo-Ehounoud; Mohamed Ben Allaoui Baby; Evelyne Aka-Diarra; Muriel Amon-Tanoh; Christian Tanoh
Journal:  Case Rep Neurol Med       Date:  2016-02-17

Review 10.  Central Disorders of Hypersomnolence.

Authors:  Lynn Marie Trotti
Journal:  Continuum (Minneap Minn)       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.